Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Diagnosis of Mondor's Disease in the Emergency Department with Bedside Ultrasound.

O'Neal JM, Castleberg E, Dinh VA.

Case Rep Emerg Med. 2015;2015:817960. doi: 10.1155/2015/817960. Epub 2015 Jan 18.

2.

Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.

Xing L, McDonald JJ, Kolodziej SA, Kurumbail RG, Williams JM, Warren CJ, O'Neal JM, Skepner JE, Roberds SL.

J Med Chem. 2011 Mar 10;54(5):1211-22. doi: 10.1021/jm101382t. Epub 2011 Feb 8.

PMID:
21302953
3.

One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation.

O'Neal JM, Diab T, Allen MR, Vidakovic B, Burr DB, Guldberg RE.

Bone. 2010 Aug;47(2):241-7. doi: 10.1016/j.bone.2010.05.016. Epub 2010 May 16.

4.

Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade.

Chaudhary KW, O'Neal JM, Mo ZL, Fermini B, Gallavan RH, Bahinski A.

Assay Drug Dev Technol. 2006 Feb;4(1):73-82.

PMID:
16506891
5.

Microinfusion using hollow microneedles.

Martanto W, Moore JS, Kashlan O, Kamath R, Wang PM, O'Neal JM, Prausnitz MR.

Pharm Res. 2006 Jan;23(1):104-13. Epub 2006 Nov 30.

PMID:
16308670
6.

Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature.

Davis TW, O'Neal JM, Pagel MD, Zweifel BS, Mehta PP, Heuvelman DM, Masferrer JL.

Cancer Res. 2004 Jan 1;64(1):279-85.

7.

Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.

Davis TW, Zweifel BS, O'Neal JM, Heuvelman DM, Abegg AL, Hendrich TO, Masferrer JL.

J Pharmacol Exp Ther. 2004 Mar;308(3):929-34. Epub 2004 Jan 7.

PMID:
14711936
8.

Elicitation, a new window into plant chemodiversity and phytochemical drug discovery.

Poulev A, O'Neal JM, Logendra S, Pouleva RB, Timeva V, Garvey AS, Gleba D, Jenkins IS, Halpern BT, Kneer R, Cragg GM, Raskin I.

J Med Chem. 2003 Jun 5;46(12):2542-7.

PMID:
12773057
9.

Plants and human health in the twenty-first century.

Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O'Neal JM, Cornwell T, Pastor I, Fridlender B.

Trends Biotechnol. 2002 Dec;20(12):522-31. Review.

PMID:
12443874
10.

Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.

Bovy PR, O'Neal JM, Olins GM, Patton DR, McMahon EG, Palomo M, Koepke JP, Salles KS, Trapani AJ, Smits GJ, et al.

J Med Chem. 1990 May;33(5):1477-82.

PMID:
2329570
11.

A synthetic linear decapeptide binds to the atrial natriuretic peptide receptors and demonstrates cyclase activation and vasorelaxant activity.

Bovy PR, O'Neal JM, Olins GM, Patton DR, Mehta PP, McMahon EG, Palomo M, Schuh J, Blehm D.

J Biol Chem. 1989 Dec 5;264(34):20309-13.

12.
13.

First person account: finding myself and loving it.

O'Neal JM.

Schizophr Bull. 1984;10(1):109-10.

PMID:
6701475

Supplemental Content

Loading ...
Support Center